Moderna's improved mRNA covid-19 vaccine is effective at lower doses
A streamlined version of Moderna’s vaccine that targets only key parts of the spike protein of the SARS-CoV-2 coronavirus is being trialled in humans
A streamlined version of Moderna’s vaccine that targets only key parts of the spike protein of the SARS-CoV-2 coronavirus is being trialled in humans
What's Your Reaction?
SIN
ScienceX Information Network (SIN) | ScienceX Innovations
